Beth Israel Medical Center is a clinical research site located in New York, New York, United States 10003.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Beth Israel Medical Center has participated in 178 clinical trials with 2 currently active.
Therapeutic areas: Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7.
Sponsors: National Cancer Institute (NCI), Radiation Therapy Oncology Group, Beth Israel Medical Center.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Medical Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Medical Center has 178 clinical trials on record, with 2 currently active. Their work covers Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7.
Beth Israel Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.